Alseres Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Report Overview

Table of Contents

157.87

Select License Type

£157.87	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£315.74	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£473.61	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£157.87	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Company Profile
Country	Global
Published	1 July 2009
Number of Pages	17
Report Delivery	Email
Delivery Lead Time	-
Publisher	Global Markets Direct

Alseres Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Alseres Pharmaceuticals, Inc. (Alseres) is a development stage biopharmaceutical company. The company is engaged in the development of drug candidates to diagnose and treat disorders in the central nervous system. It also focuses on developing therapeutic and diagnostic products. It has advanced technology base which are used for developing products in regenerative therapeutics program, Molecular Imaging Program, neurodegenerative disease program to improve the quality of life of patients. It is headquartered in Hopkinton in Massachusetts, United States.

The Alseres Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£157.87	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£315.74	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£473.61	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£157.87	Add to Wishlist
Change Currency	GBP EURO USD

Table Of Contents
Table Of Contents 2
List of Tables 2
List of Figures 2
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 6
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 8
Equity Offering 8
Alseres Issues Convertible Preferred Stock For $1 Million 8
Alseres Pharmaceuticals Completes Private Placement Of $0.2 Million 9
Alseres Pharmaceuticals Completes Private Placement Of $1 Million 10
Alseres Pharmaceuticals Completes Private Placememt Of $1 Million 11
Boston Life Sciences Completes Private Placement Of $12.78 Million 12
Boston Life Sciences Completes Private Placement Of $5 Million 13
Partnerships 14
Alseres Pharmaceuticals Partners With QSV Biologics 14
Boston Life Sciences Enters Into A Licensing Agreement With BioAxone Therapeutic 15
Key Competitors 16
Key Employees 16
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About Global Markets Direct 17
Contact Us 17
Disclaimer 17

List of Tables
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Alseres Pharmaceuticals, Inc., Deals By Sector, 2004 to YTD 2009 6
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7
Alseres Issues Convertible Preferred Stock For $1 Million 8
Alseres Pharmaceuticals Completes Private Placement Of $0.2 Million 9
Alseres Pharmaceuticals Completes Private Placement Of $1 Million 10
Alseres Pharmaceuticals Completes Private Placememt Of $1 Million 11
Boston Life Sciences Completes Private Placement Of $12.78 Million 12
Boston Life Sciences Completes Private Placement Of $5 Million 13
Alseres Pharmaceuticals Partners With QSV Biologics 14
Boston Life Sciences Enters Into A Licensing Agreement With BioAxone Therapeutic 15
Alseres Pharmaceuticals, Inc., Key Employees 16

List of Figures
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 4
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Alseres Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 6

Change Currency

GBP

EURO

USD

Last Viewed

Alseres Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hanger Orthopedic Group, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Germany Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

AmerisourceBergen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Alseres Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel